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SUPPRESSION OF MILIARIA RUBRA (PRICKLY HEAT) BY A TOPICAL
AXTICHOLINERGIC AGENT*
R. B. STOUGHTON, M.D.
Shelley and Horvath reported suppression of
experimental miliaria rubra and crystallina by the
intradermal injection of 0.05 mgm of atropine
sulfate (1,2). It is also known that eccrine sweat-
ing in man can be suppressed by topical applica-
tion of anticholinergic agents (3, 4, 5). Details of
such suppression with hexopyrronium bromide
(AHR-483)t were reported recently (4). It there-
fore seemed possible that prevention and manage-
ment of miliaria could be accomplished by topical
application of an anticholinergic agent.
Some subjects consistently develop miliaria
rubra following occlusive wrapping of normal
skin. Most of these subjects who develop miliaria
rubra do so every time the skin area is occluded.
It was observed that the application of hexo-
pyrronium bromide to a small area on the forearm
before occlusive wrapping prevented the develop-
ment of miliaria rubra in this local area of applica-
tion while surrounding untreated areas developed
typical miliaria rubra. Because of this finding in
experimental miliaria rubra, it was decided to try
the local application of hexopyrronium bromide
for clinical miliaria rubra.
METHODS ANI) liESTJLT5
Hexopyrronium bromide (AHR-483) which was
supplied as a powder for this study, was diluted in
95% alcohol to make a 0.5% solution (weight/
volume). This solution was used for the experi-
mental and clinical studies and was made within
one week of the time of use.
In the study of experimental miliaria, six
subjects were used to demonstrate suppression of
miliaria rubra by AHR-483 following occlusion.
Hexopyrronium bromide, 0.5%, 0.02 cc, was ap-
plied to a 2—3 sq cm area of the forearm and the
entire forearm was then occluded for 16—17 hours.
This procedure was repeated for three days. Eight
hours after the last occlusion, miliaria rubra was
produced by placing the subjects in a room of 35-38°
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C. (relative humidity 25—40%) for 30—60 minutes.
Relatively severe miliaria rubra developed in the
occluded areas not treated with hexopyrronium
bromide. The occluded area treated with hexo-
pyrroniurn bromide remained free of lesions.
Four subjects with clinical miliaria rubra in
summer (Cleveland, July, 1963) were treated with
hexopyrronium bromide. Subjects were all males
ranging in age from 14 months to 42 years. The
treatment period was 2—5 days. Subjects applied
hexopyrronium bromide 0.5% topically three times
per day to localized areas leaving some diseased
areas untreated. All four subjects with clinical
miliaria rubra showed clearing of the lesions in
24—48 hours where hexopyrronium bromide had
been applied. The surrounding, untreated skin
maintained the lesions of miliarja rubra. One sub-
ject cleared everywhere spontaneously in 2—3 days.
This coincided with the onset of cooler weather.
CONCLUSIONS
Both clinical and experimental miliaria rubra
can be almost completely suppressed by topical
applications of the anticholinergic agent, hexo-
pyrronium bromide.
The rapid clearing of clinical miliaria rubra in
the areas of topical application of hexopyrronium
bromide indicates that this type of agent will
control the basic disease, miliaria rubra, presum-
ably by suppression of the secretory activity of
the eccrine sweat glands.
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